Literature DB >> 2391421

The importance of mast cells for the neutrophil influx in immune complex-induced peritonitis in mice.

B F Ramos1, R Qureshi, K M Olsen, B A Jakschik.   

Abstract

The role of mast cells in polymorphonuclear leukocyte (PMN) influx in Ag-antibody complex-induced peritonitis was evaluated in mast cell-deficient WBB6F1-W/Wv (W/Wv) mice and their normal littermates, WBB6F1-+/+ (+/+). Peritoneal cell influx was evaluated after i.p. injection of preformed immune complexes. The first significant elevation in the PMN count over PBS-treated controls in +/+ mice was observed 2 h after stimulation. During the period of maximum leukocyte concentrations (6 to 10 h), the increase in total cell count was 5-fold and in PMN 25-fold. In W/Wv mice the PMN influx started 2 h later than in the +/+ mice, and the maximum response (8 to 10 h) was only 50% of that in controls. Reconstitution of mast cells in W/Wv mice for 2 wk or more restored the PMN response to immune complexes. Mast cell release due to AG-antibody complexes was evaluated by measuring fluorescence intensity after berberine sulfate staining for heparin in mast cells from unstimulated as well as stimulated +/+ mice. There was a significant decrease in fluorescence intensity as early as 15 min after stimulation. By 30 min the fluorescence intensity had declined by 65%. This indicates extensive mast cell release that started before PMN mobilization. These experiments demonstrate that mast cells make a significant contribution to immune complex-induced inflammation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391421

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Pathogenesis of B-cell superantigen-induced immune complex-mediated inflammation.

Authors:  Amy L Anderson; Romeo Sporici; John Lambris; David Larosa; Arnold I Levinson
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

2.  Interleukin 8 and mast cell-generated tumor necrosis factor-alpha in neutrophil recruitment.

Authors:  Y Zhang; B F Ramos; B Jakschik; M P Baganoff; C L Deppeler; D M Meyer; D L Widomski; D J Fretland; M A Bolanowski
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

Review 3.  The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.

Authors:  S J Galli; M Tsai; B K Wershil
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

4.  Development of specific antibody and in vivo response to antigen in different rat strains: effect of dexamethasone and importance of endogenous corticosteroids.

Authors:  S H Peers; G S Duncan; R J Flower
Journal:  Agents Actions       Date:  1993-07

5.  Role of mast cells in plasma permeation due to immune injury of the skin basement membrane.

Authors:  Y Zhang; B F Ramos; B A Jakschik
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

6.  Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice.

Authors:  R Malaviya; E Ross; B A Jakschik; S N Abraham
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Role of mast cells in calcium ionophore (A23187)-induced peritoneal inflammation in mice.

Authors:  T S Rao; A F Shaffer; J L Currie; P C Isakson
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

8.  Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation.

Authors:  T S Rao; J L Currie; A F Shaffer; P C Isakson
Journal:  Inflammation       Date:  1993-12       Impact factor: 4.092

9.  Mast cells mediate acute inflammatory responses to implanted biomaterials.

Authors:  L Tang; T A Jennings; J W Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Augmentation of reverse arthus reaction by mast cells in mice.

Authors:  Y Zhang; B F Ramos; B A Jakschik
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.